Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.1 USD | -2.99% |
|
-3.57% | -0.78% |
06-28 | Activist investor Oasis launches campaign against Japan drug store chain Ain | RE |
06-10 | Japan's Nikkei ends higher led by financials, export shares | RE |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Sales forecast by analysts have been recently revised upwards.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 28.52 times its estimated earnings per share for the ongoing year.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.78% | 18.85B | - | ||
-9.01% | 235B | B- | ||
0.00% | 19.58B | - | - | |
+7.90% | 11.4B | A- | ||
-19.32% | 8.65B | A- | ||
+15.38% | 7.45B | B+ | ||
+11.66% | 6.03B | B | ||
-7.99% | 3.87B | B+ | ||
-19.43% | 3.72B | C- | ||
-3.22% | 3.63B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4452 Stock
- KAOOY Stock
- Ratings Kao Corporation